NovaSight
PrivateLast Round
Series B
Mar 1, 2024
Total Funding Raised
$23M
Company Overview
NovaSight operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a Series A round in July 2020.
NovaSight is a therapeutic devices company that develops eye-tracking-based solutions for the diagnosis and treatment of pediatric vision disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Patient Engagement, Telemedicine
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NovaSight Comparables
Compare NovaSight with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Luminopia, Inc. | 87% | |
| Hundred Vision | 84% | |
| Vivid Vision | 83% |
For institutional investors. Book with your work email.
NovaSight Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 1, 2024 | ||||
| Series A | Jul 13, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NovaSight Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rimonci | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 9, 2025
Monthly visitors increased 264% MoM, reaching 8.4K.
- May 2, 2025
Monthly visitors grew 117% MoM, reaching 2.6K.
For institutional investors. Book with your work email.
NovaSight Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NovaSight's valuation, stock price, and market status.
Is NovaSight a public or private company?
NovaSight is a private company.
What is the current stock price of NovaSight?
NovaSight is a private company, so its shares have no public market price. Caplight tracks NovaSight's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NovaSight worth (valuation)?
Valuation information for NovaSight is not publicly available.
Can I buy NovaSight stock?
NovaSight shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NovaSight's last funding round?
NovaSight's most recent funding round was Series B on March 1, 2024.
Who are the main investors in NovaSight?
Key investors in NovaSight include Rimonci.
Will NovaSight IPO soon?
No public IPO plans have been announced for NovaSight.
How can I track NovaSight secondary market activity?
Caplight tracks bids, offers, and trades in NovaSight's shares on secondary markets.